Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|February 2, 2019
Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemiaGuoqiao Zheng, Subhayan Chattopadhyay, Amit Sud, et al.
International Journal of Cancer|May 5, 2019
Second primary cancers in non-Hodgkin lymphoma: Family history and survivalSubhayan Chattopadhyay, Guoqiao Zheng, Amit Sud, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Leveraging Human Genetics to Guide Cancer Drug DevelopmentBen Kinnersley, Amit Sud, Elizabeth A Coker, et al.
Blood Cancer Journal|April 8, 2025
Mendelian randomization of immune cell phenotypes to discover potential drug targets for B-cell malignancySina A Beer, Molly Went, Charlie Mills, et al.
International Journal of Cancer|September 22, 2018
Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunctionSubhayan Chattopadhyay, Amit Sud, Guoqiao Zheng, et al.
Blood Neoplasia|March 20, 2026
Proteome-wide Mendelian randomization identifies protein associations and therapeutic targets for B-cell malignancyMolly Went, Charlie Mills, Amit Sud, et al.
The Lancet. Haematology|August 5, 2018
Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer: a nationwide, observational follow up study in SwedenSubhayan Chattopadhyay, Guoqiao Zheng, Amit Sud, et al.
NPJ Precision Oncology|May 28, 2024
Genetic landscape of interval and screen detected breast cancerCharlie Mills, Amit Sud, Andrew Everall, et al.
Nature Genetics|June 18, 2024
Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncologyBen Kinnersley, Amit Sud, Andrew Everall, et al.
Research Square|March 30, 2023
Risk factors for eight common cancers revealed from a phenome-wide Mendelian randomisation analysis of 378,142 cases and 485,715 controlsMolly Went, Amit Sud, Charlie Mills, et al.
Pageof 7